LSEQ yields 1.84% · JNJ yields 2.14%● Live data
📍 JNJ pulled ahead of the other in Year 7
Combined, LSEQ + JNJ cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of LSEQ + JNJ for your $10,000?
LSEQ is the first known hedge fund to ETF conversion in the industry. The fund aims to optimize returns while managing risk amid evolving market conditions by balancing long and short positions in US large and mid-cap stocks. The fund utilizes a multifactor model for long positions and a dedicated short model to identify potential underperformers. The approach is a proprietary macroeconomic regime model, which classifies market environments into value, neutral, or momentum regimes. This model determines gross and net exposure levels, value, quality, profitability, and momentum. Industry group selection is based on perceived alpha opportunities, focusing on sectors exhibiting the highest return dispersion. To manage risk, the fund maintains long and short exposures to counteract downside tail risk, gauged by the Sortino ratio. Investments may include T-bills, derivatives, limited foreign exposure, and reverse repurchase agreements. LSEQ started with $3.64 million in net assets.
Full LSEQ Calculator →Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide, but strategically separated its Consumer Health business into Kenvue Inc. in 2023 to focus on its higher-growth, innovation-driven segments; the former Consumer Health brands (including TYLENOL, LISTERINE, and BAND-AID) are now owned by Kenvue. The company's core focus is now split between its Innovative Medicine (formerly Pharmaceutical) segment, which offers prescription products for complex diseases such as rheumatoid arthritis, various cancers, HIV/AIDS, and neurodegenerative disorders; and its MedTech (Medical Devices) segment, which provides advanced technology solutions including electrophysiology products, neurovascular care products, orthopaedics (hips, knees, spine), advanced surgery solutions, and disposable contact lenses under the ACUVUE brand. Company's two remaining segments primarily serve hospitals, healthcare professionals, wholesalers, and retailers, continuing its mission of advancing human health since its founding in 1886 and its current basing in New Brunswick, New Jersey.
Full JNJ Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.